Engler H, Riesen W F, Keller B
Institut für klinische Chemie und Hämatologie des Kantons St. Gallen.
Schweiz Med Wochenschr. 1992 Dec 26;122(51-52):1976-80.
With the identification of thyroid peroxidase (TPO) as the main antigen of the thyroid microsomal fraction, the development of a sensitive and specific assay for detection of these antibodies became possible. The diagnostic value of the anti-TPO assay was evaluated in patients with different types of thyroid disease and in controls. 65% of patients with thyroiditis had elevated anti-TPO values. The frequency of elevated anti-TPO levels in patients with active autoimmune thyroiditis was 90% (clinical diagnosis Hashimoto thyroiditis) compared to 64% in patients with overt hyperthyroidism (clinical diagnosis Graves' disease). None of the controls or the patient with non-thyroidal illness showed elevated anti-TPO levels.
随着甲状腺过氧化物酶(TPO)被确定为甲状腺微粒体部分的主要抗原,开发一种灵敏且特异的检测这些抗体的方法成为可能。在患有不同类型甲状腺疾病的患者及对照组中评估了抗TPO检测的诊断价值。65%的甲状腺炎患者抗TPO值升高。活动性自身免疫性甲状腺炎患者中抗TPO水平升高的频率为90%(临床诊断为桥本甲状腺炎),而显性甲状腺功能亢进患者(临床诊断为格雷夫斯病)中这一比例为64%。对照组或非甲状腺疾病患者中均未显示抗TPO水平升高。